Zeiher Bernhardt G 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Zeiher Bernhardt G
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-14+50,000→ 50,000 totalExercise: $3.17Exp: 2034-03-13→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer.